Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
Jason M. Meggs net worth and biography

Jason Meggs Biography and Net Worth

Jason Meggs serves as Chief Financial Officer of the Company. He was appointed Chief Financial Officer ("CFO") in May 2018 after serving as Executive Vice President and Interim CFO beginning in February 2018. Prior to his appointment to this role, he served as Executive Vice President and CFO of the Commercial Solutions segment of the Company from August 2017 to February 2018. He also previously served as Executive Vice President, Oncology Operations of the Company from January 2017 to August 2017 and Senior Vice President, Business Finance of the Company from 2014 to 2016. Prior to joining the Company, Mr. Meggs was Global Vice President, Internal Audit, at Quintiles Transnational Corporation, a leading global CRO, from 2013 to 2014 and held a number of finance roles at Quintiles from 2005 to 2013. He began his career as an auditor with Deloitte & Touche LLP and Arthur Anderson LLP, and is a certified public accountant. He currently serves as Treasurer for the ACRO. He received his Bachelor of Science in Business Administration degree with a Major in Accounting from Western Carolina University.

What is Jason M. Meggs' net worth?

The estimated net worth of Jason M. Meggs is at least $1.98 million as of July 18th, 2022. Mr. Meggs owns 54,736 shares of Syneos Health stock worth more than $1,975,422 as of January 30th. This net worth approximation does not reflect any other investments that Mr. Meggs may own. Learn More about Jason M. Meggs' net worth.

What is Jason M. Meggs' salary?

As the CFO of Syneos Health, Inc., Mr. Meggs earned a total compensation package of $2,623,581.00 in 2021. Mr. Meggs earned a salary of $600,000.00, stock awards of $2,012,808.00, and other compensation of $10,773.00. Learn More on Jason M. Meggs' salary.

How do I contact Jason M. Meggs?

The corporate mailing address for Mr. Meggs and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected] Learn More on Jason M. Meggs' contact information.

Has Jason M. Meggs been buying or selling shares of Syneos Health?

Jason M. Meggs has not been actively trading shares of Syneos Health within the last three months. Most recently, Jason M. Meggs sold 7,500 shares of the business's stock in a transaction on Monday, July 18th. The shares were sold at an average price of $72.81, for a transaction totalling $546,075.00. Following the completion of the sale, the chief financial officer now directly owns 54,736 shares of the company's stock, valued at $3,985,328.16. Learn More on Jason M. Meggs' trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 9 times. They sold a total of 23,458 shares worth more than $1,741,262.57. The most recent insider tranaction occured on July, 28th when COO Michael Lee Brooks sold 1,002 shares worth more than $78,156.00. Insiders at Syneos Health own 0.3% of the company. Learn More about insider trades at Syneos Health.

Information on this page was last updated on 7/28/2022.

Jason M. Meggs Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/18/2022Sell7,500$72.81$546,075.0054,736View SEC Filing Icon  
9/3/2021Sell9,223$95.00$876,185.0051,478View SEC Filing Icon  
7/6/2021Sell660$90.00$59,400.0060,741View SEC Filing Icon  
6/30/2021Sell4,668$90.00$420,120.00View SEC Filing Icon  
4/15/2021Sell6,000$84.00$504,000.0060,701View SEC Filing Icon  
1/6/2021Sell5,552$72.00$399,744.0064,503View SEC Filing Icon  
11/27/2020Sell4,062$67.00$272,154.0066,003View SEC Filing Icon  
11/24/2020Sell1,938$67.00$129,846.0070,065View SEC Filing Icon  
3/20/2020Buy3,555$36.74$130,610.7063,784View SEC Filing Icon  
12/17/2018Buy3,650$41.25$150,562.50View SEC Filing Icon  
See Full Table

Jason M. Meggs Buying and Selling Activity at Syneos Health

This chart shows Jason M Meggs's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. engages in the provision of outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.
Read More

Today's Range

Now: $36.09
Low: $35.69
High: $36.48

50 Day Range

MA: $35.01
Low: $33.18
High: $36.93

2 Week Range

Now: $36.09
Low: $22.89
High: $92.62


868,800 shs

Average Volume

1,825,078 shs

Market Capitalization

$3.71 billion

P/E Ratio


Dividend Yield



Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.